Bill Commons

DE HB 395

Status unknown

AN ACT TO AMEND TITLES 3, 4, AND 16 OF THE DELAWARE CODE RELATING TO HEMP, MARIJUANA, AND MARIJUANA PRODUCTS.

Delaware · 2025-2026 Regular Session (153rd General Assembly) · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did DE HB 395 pass?

The current status of DE HB 395 is not known from the official record. Latest recorded action (2026-06-16): Assigned to Health & Social Services Committee in Senate

What is DE HB 395 about?

The General Assembly recognizes that Delaware’s industrial hemp farmers and processors play an important role in the State’s agricultural economy and that non-intoxicating industrial hemp products are lawful and should continue to be cultivated, produced, and sold in accordance with state and federal law. Nothing in this Act is intended to criminalize lawful industrial hemp or disrupt the legitimate industrial hemp industry. The General Assembly finds that an unregulated market for intoxicating THC consumable products has emerged in Delaware, notwithstanding prior legislation making clear that intoxicating products derived from the cannabis plant are marijuana and must be sold only in licensed, regulated establishments. Intoxicating consumable products containing high levels of THC are now widely available in retail outlets, many of which operate in and target our most vulnerable communities. These products are frequently sold without age restrictions, product testing, potency limits, or meaningful labeling, and are often marketed in ways that make them especially appealing and accessible to minors. This Act reaffirms Delaware’s commitment to a responsible adult-use marijuana industry by ensuring that all cannabis-related products sold in this State meet the highest standards of health and safety. To that end, the Act strengthens the requirement that consumable products containing a specified level of THC, regardless of their source, be sold only through licensed establishments and be subject to appropriate regulatory oversight. By ensuring these products are integrated into Delaware’s existing, comprehensive regulatory framework for adult-use marijuana—which includes stringent testing, labeling, packaging, and age-restriction requirements—this Act safeguards public health and prevents unregulated intoxicating THC consumable products from undermining the safety protections established for Delawareans, particularly children and adolescents.

Who sponsors DE HB 395?

Stell Parker Selby, Darius J. Brown, Russell Huxtable and 2 others are the primary sponsors of DE HB 395.

Description

The General Assembly recognizes that Delaware’s industrial hemp farmers and processors play an important role in the State’s agricultural economy and that non-intoxicating industrial hemp products are lawful and should continue to be cultivated, produced, and sold in accordance with state and federal law. Nothing in this Act is intended to criminalize lawful industrial hemp or disrupt the legitimate industrial hemp industry. The General Assembly finds that an unregulated market for intoxicating THC consumable products has emerged in Delaware, notwithstanding prior legislation making clear that intoxicating products derived from the cannabis plant are marijuana and must be sold only in licensed, regulated establishments. Intoxicating consumable products containing high levels of THC are now widely available in retail outlets, many of which operate in and target our most vulnerable communities. These products are frequently sold without age restrictions, product testing, potency limits, or meaningful labeling, and are often marketed in ways that make them especially appealing and accessible to minors. This Act reaffirms Delaware’s commitment to a responsible adult-use marijuana industry by ensuring that all cannabis-related products sold in this State meet the highest standards of health and safety. To that end, the Act strengthens the requirement that consumable products containing a specified level of THC, regardless of their source, be sold only through licensed establishments and be subject to appropriate regulatory oversight. By ensuring these products are integrated into Delaware’s existing, comprehensive regulatory framework for adult-use marijuana—which includes stringent testing, labeling, packaging, and age-restriction requirements—this Act safeguards public health and prevents unregulated intoxicating THC consumable products from undermining the safety protections established for Delawareans, particularly children and adolescents.

Introduced
2026-04-30
Latest action
2026-06-16 — Assigned to Health & Social Services Committee in Senate
Bill type
bill
Last updated
—

Sponsors

  • Stell Parker Selbyprimary
  • Darius J. Brownprimary
  • Russell Huxtableprimary
  • Edward S. Osienskiprimary
  • Nnamdi O. Chukwuochaprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-06-16

    Assigned to Health & Social Services Committee in Senate

    introduction,referral-committee

  2. 2026-06-16

    Passed By House. Votes: 35 YES 4 NO 2 ABSENT

    passage

  3. 2026-06-16

    Amendment HA 1 to HB 395 - Passed In House by Voice Vote

    amendment-passage

  4. 2026-06-16

    Amendment HA 1 to HB 395 - Introduced and Placed With Bill

    amendment-introduction

  5. 2026-05-14

    Reported Out of Committee (Health & Human Development) in House with 3 Favorable, 6 On Its Merits

    committee-passage,committee-passage-favorable

  6. 2026-04-30

    Re-Assigned to Health & Human Development Committee in House

    introduction,referral-committee

  7. 2026-04-30

    Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

    introduction,referral-committee

Versions

Documents

Votes

  • SM

    2026-06-16 · pass · 35-4

    Member-level votes (41)
    • Alonna Berry: yes
    • Stephanie T. Bolden: yes
    • Frank Burns: no
    • William Bush: yes
    • William J. Carson: yes
    • Nnamdi O. Chukwuocha: yes
    • Richard G. Collins: no
    • Franklin D. Cooke: yes
    • Daniel B. Short: yes
    • Timothy D. Dukes: yes
    • Mara Gorman: yes
    • Ronald E. Gray: yes
    • Krista Griffith: yes
    • Kerri Evelyn Harris: yes
    • Debra Heffernan: yes
    • Kevin S Hensley: other
    • Jeff Hilovsky: yes
    • Valerie Jones Giltner: yes
    • Kendra Johnson: yes
    • Kimberly Williams: yes
    • Kamela T Smith: yes
    • Larry Lambert: yes
    • Sean M. Lynn: yes
    • Michael F. Smith: yes
    • Melissa Minor-Brown: yes
    • Shannon Morris: yes
    • Eric Morrison: no
    • DeShanna U Neal: yes
    • Josue O Ortega: yes
    • Edward S. Osienski: yes
    • Sophie Phillips: yes
    • Charles S Postles Jr.: other
    • Cyndie Romer: yes
    • Melanie Ross Levin: yes
    • Sherae'a Moore: yes
    • Bryan W. Shupe: yes
    • Claire Snyder-Hall: no
    • Jeffrey N. Spiegelman: yes
    • Jesse R. Vanderwende: yes
    • Madinah Wilson-Anton: yes
    • Lyndon D. Yearick: yes

Related bills

No related bills recorded for this bill.

Official source

https://legis.delaware.gov/BillDetail?LegislationId=143192

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T03:53:51.443619Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changesStatus and relationship changes

Session-wide evidence can include changes to other bills:

Bulk imports for this sessionSession dates and activity

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=DE&identifier=HB 395. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.